These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25373630)

  • 21. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
    Craft S; Baker LD; Montine TJ; Minoshima S; Watson GS; Claxton A; Arbuckle M; Callaghan M; Tsai E; Plymate SR; Green PS; Leverenz J; Cross D; Gerton B
    Arch Neurol; 2012 Jan; 69(1):29-38. PubMed ID: 21911655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Placebo-Controlled, Parallel-Group, Randomized Clinical Trial of AC-1204 in Mild-to-Moderate Alzheimer's Disease.
    Henderson ST; Morimoto BH; Cummings JL; Farlow MR; Walker J
    J Alzheimers Dis; 2020; 75(2):547-557. PubMed ID: 32310169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
    Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
    Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered small-world anatomical networks in Apolipoprotein-E4 (ApoE4) carriers using MRI.
    Goryawala M; Zhou Q; Duara R; Loewenstein D; Cabrerizo M; Barker W; Adjouadi M
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():2468-71. PubMed ID: 25570490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease.
    Morris JK; Uy RAZ; Vidoni ED; Wilkins HM; Archer AE; Thyfault JP; Miles JM; Burns JM
    J Alzheimers Dis; 2017; 58(4):1129-1135. PubMed ID: 28550261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.
    Kennedy RE; Cutter GR; Wang G; Schneider LS
    J Alzheimers Dis; 2016; 50(4):1205-15. PubMed ID: 26836180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
    Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
    J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.
    Reger MA; Watson GS; Green PS; Baker LD; Cholerton B; Fishel MA; Plymate SR; Cherrier MM; Schellenberg GD; Frey WH; Craft S
    J Alzheimers Dis; 2008 Apr; 13(3):323-31. PubMed ID: 18430999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.
    Blautzik J; Kotz S; Brendel M; Sauerbeck J; Vettermann F; Winter Y; Bartenstein P; Ishii K; Rominger A;
    J Alzheimers Dis; 2018; 65(3):781-791. PubMed ID: 28697560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E4 allele.
    Qiu WQ; Mwamburi M; Besser LM; Zhu H; Li H; Wallack M; Phillips L; Qiao L; Budson AE; Stern R; Kowall N
    J Alzheimers Dis; 2013; 37(2):421-8. PubMed ID: 23948883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketogenic diet rescues cognition in ApoE4+ patient with mild Alzheimer's disease: A case study.
    Morrill SJ; Gibas KJ
    Diabetes Metab Syndr; 2019; 13(2):1187-1191. PubMed ID: 31336463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
    Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
    Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study.
    Henderson ST; Poirier J
    BMC Med Genet; 2011 Oct; 12():137. PubMed ID: 21992747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women: implications for late onset Alzheimer's disease.
    Karim R; Koc M; Rettberg JR; Hodis HN; Henderson VW; St John JA; Allayee H; Brinton RD; Mack WJ
    Menopause; 2019 Jan; 26(1):7-15. PubMed ID: 29975287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of apolipoproteins e4 and c1 with onset age and memory: a study of sporadic Alzheimer disease in Taiwan.
    Chuang WL; Hsieh YC; Wang CY; Kuo HC; Huang CC
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):42-8. PubMed ID: 20145290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease.
    Qiu WQ; Zhu H; Dean M; Liu Z; Vu L; Fan G; Li H; Mwamburi M; Steffens DC; Au R
    Int J Geriatr Psychiatry; 2016 Mar; 31(3):316-22. PubMed ID: 26250797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease.
    Stein MS; Scherer SC; Ladd KS; Harrison LC
    J Alzheimers Dis; 2011; 26(3):477-84. PubMed ID: 21694461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E genotype and physical function among older people with mild cognitive impairment.
    Doi T; Shimada H; Makizako H; Tsutsumimoto K; Uemura K; Suzuki T
    Geriatr Gerontol Int; 2015 Apr; 15(4):422-7. PubMed ID: 24730603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.